CTIS2023-505507-22-00进行中（未招募）1 期
PENTALON - Pilot study for the evaluation of [68Ga]Ga-PentixaFor PET imaging for the identification of unilateral adrenal secretion of ALdosterON in patients with primary aldosteronism. - APHP220881
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Age = 18 years old, Signed written informed consent, French Social Security affiliation, For child-bearing aged women, efficient contraception, Diagnosis of primary aldosteronism: -With or without adrenal nodule on morphological imaging (CT or Magnetic Resonance Imaging) -With unilateral or bilateral aldosterone secretion confirmed by invasive AVS
排除标准
- •Pregnant or breastfeeding women, Patient under legal protection (guardianship), Contraindication to the PET-CT, Contraindication to the injection of [68Ga]Ga-PentixaFor, Participation in another interventional study involving human participants or being in the exclusion period at the end of a previous study involving human participants, if applicable, Patient on AME (state medical aid) (unless exemption from affiliation), Completed group: if the expected number of patients has been reached (15 patients) in the corresponding group of patients (with lateralized or non-lateralized PA).
研究者
相似试验
已完成
不适用
Pilot Study – Use of [68Ga] gallium-labelled Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) for the Characterisation of Metastatic Lesions in Patients with Renal Cell CarcinomaACTRN12615000854538Dr Simon Wood10
已完成
不适用
Genesis GBM 001 Phase I/II study of 68Ga-PSMA as a tumour targeting agent in relapsed glioblastomaBrain CancerGlioblastomaBrain CancerCancer - BrainGlioblastomaACTRN12618001346268Genesis Care11
进行中（未招募）
不适用
A prospective study of the use of 68Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors.Patients with neuroendocrine tumors, who are going to be diagnosed/evaluated with 68Ga-DOTA-TATE PET/CT instead of standard OctreoscanMedDRA version: 14.1Level: LLTClassification code 10062476Term: Neuroendocrine tumorSystem Organ Class: 100000004864EUCTR2012-004313-13-SESkåne University Hospital, Dept of Oncology450
已完成
不适用
A prospective feasibility study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung canceron-small cell lung cancerCancer - Lung - Non small cellNon-small cell lung cancerACTRN12613000061730Peter MacCallum Cancer Centre60
尚未招募
不适用
18FGE-180-Positron Emission Tomography in Graft Versus Host DiseaseACTRN12617000933358Royal Brisbane and Women's Hospital10